These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12929421)
1. Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs. Chen YJ; Gao LJ; Murad I; Verstuyf A; Verlinden L; Verboven C; Bouillon R; Viterbo D; Milanesio M; Van Haver D; Vandewalle M; De Clercq PJ Org Biomol Chem; 2003 Jan; 1(2):257-67. PubMed ID: 12929421 [TBL] [Abstract][Full Text] [Related]
2. Biological activity and conformational analysis of C20 and C14 epimers of CD-ring modified trans-decalin 1alpha,25-dihydroxyvitamin D analogs. De Clercq PJ; Murad I; Gao LJ; Chen YJ; Van Haver D; Vandewalle M; Verstuyf A; Verlinden L; Verboven C; Bouillon R J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):61-6. PubMed ID: 15225748 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018 [TBL] [Abstract][Full Text] [Related]
4. Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity. Verlinden L; Verstuyf A; Verboven C; Eelen G; De Ranter C; Gao LJ; Chen YJ; Murad I; Choi M; Yamamoto K; Yamada S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R J Biol Chem; 2003 Sep; 278(37):35476-82. PubMed ID: 12829710 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues. Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs. Takayama H; Kittaka A; Fujishima T; Suhara Y Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3. Fujishima T; Liu Z; Miura D; Chokki M; Ishizuka S; Konno K; Takayama H Bioorg Med Chem Lett; 1998 Aug; 8(16):2145-8. PubMed ID: 9873502 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activities of 26-hydroxy-27-nor-derivatives of 1 alpha, 25-dihydroxyvitamin D3. Scheddin D; Mayer H; Wittmann S; Schönecker B; Gliesing S; Reichenbächer M Steroids; 1996 Oct; 61(10):598-608. PubMed ID: 8910973 [TBL] [Abstract][Full Text] [Related]
10. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055 [TBL] [Abstract][Full Text] [Related]
11. 1 alpha,25-dihydroxyvitamin D3 analogs featuring aromatic and heteroaromatic rings: design, synthesis, and preliminary biological testing. Posner GH; Li Z; White MC; Vinader V; Takeuchi K; Guggino SE; Dolan P; Kensler TW J Med Chem; 1995 Oct; 38(22):4529-37. PubMed ID: 7473581 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and calcemic actions of trans-decalin CD-ring analogs of 1,25-dihydroxyvitamin D3. Eelen G; Verlinden L; Laureys J; Marcelis S; De Clercq P; Mathieu C; Bouillon R; Verstuyf A Anticancer Res; 2009 Sep; 29(9):3579-84. PubMed ID: 19667151 [TBL] [Abstract][Full Text] [Related]
13. Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogues of 1 alpha,25-dihydroxyvitamin D3(1a). Figadère B; Norman AW; Henry HL; Koeffler HP; Zhou JY; Okamura WH J Med Chem; 1991 Aug; 34(8):2452-63. PubMed ID: 1652020 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators. Fujishima T; Kittaka A; Yamaoka K; Takeyama K; Kato S; Takayama H Org Biomol Chem; 2003 Jun; 1(11):1863-9. PubMed ID: 12945766 [TBL] [Abstract][Full Text] [Related]
15. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications. Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144 [TBL] [Abstract][Full Text] [Related]
16. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. Sicinski RR; Prahl JM; Smith CM; DeLuca HF J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of 8(14)a-homocalcitriol. Steinmeyer A; Neef G; Kirsch G; Schwarz K; Rach P; Haberey M; Thieroff-Ekerdt R Steroids; 1992 Sep; 57(9):447-52. PubMed ID: 1333655 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT). Hatakeyama S; Okano T; Maeyama J; Esumi T; Hiyamizu H; Iwabuchi Y; Nakagawa K; Ozono K; Kawase A; Kubodera N Bioorg Med Chem; 2001 Feb; 9(2):403-15. PubMed ID: 11249133 [TBL] [Abstract][Full Text] [Related]
19. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3. Bouillon R; Sarandeses LA; Allewaert K; Zhao J; Mascareñas JL; Mouriño A; Vrielynck S; de Clercq P; Vandewalle M J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3. Sicinski RR; DeLuca HF Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]